Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Jennifer Doudna
Research
CRISPR pioneer looks to tech's past, future in new review
Nobel Laureate Jennifer Doudna, Ph.D., predicts a bright future for the tech, complicated by a need for better delivery and high manufacturing costs.
Helen Floersh
Jan 24, 2023 10:35am
Biogen takes another dip into Scribe gene therapy collab
May 2, 2022 3:03pm
CRISPR patent dispute not over yet as universities appeal
Apr 4, 2022 5:55pm
Bayer bolsters gene therapy ambition with Mammoth CRISPR deal
Jan 10, 2022 2:30am
Excision's HIV CRISPR therapy cleared for human studies by FDA
Sep 17, 2021 10:10am
Mammoth nets $195M to supercharge CRISPR diagnostics, medicines
Sep 9, 2021 9:00am